Page last updated: 2024-10-31

midazolam and Adult Spinal Muscular Atrophy

midazolam has been researched along with Adult Spinal Muscular Atrophy in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Research Excerpts

ExcerptRelevanceReference
" While many pediatric patients receive risdiplam, a drug-drug interaction (DDI) study in pediatric patients with SMA was not feasible."1.62Model-Based Drug-Drug Interaction Extrapolation Strategy From Adults to Children: Risdiplam in Pediatric Patients With Spinal Muscular Atrophy. ( Aarons, L; Cleary, Y; Galetin, A; Gertz, M; Grimsey, P; Günther, A; Heinig, K; Kletzl, H; Ogungbenro, K, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cleary, Y1
Gertz, M1
Grimsey, P1
Günther, A1
Heinig, K1
Ogungbenro, K1
Aarons, L1
Galetin, A1
Kletzl, H1

Other Studies

1 other study available for midazolam and Adult Spinal Muscular Atrophy

ArticleYear
Model-Based Drug-Drug Interaction Extrapolation Strategy From Adults to Children: Risdiplam in Pediatric Patients With Spinal Muscular Atrophy.
    Clinical pharmacology and therapeutics, 2021, Volume: 110, Issue:6

    Topics: Adolescent; Adult; Azo Compounds; Child; Child, Preschool; Cytochrome P-450 CYP3A Inhibitors; Drug I

2021